UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EWCZ
2326
DELISTED
European Wax Center
EWCZ
| $403K | ﹤0.01% |
21,187
| – | – |
|
|
AAN
2327
DELISTED
The Aaron's Company Inc
AAN
| $401K | ﹤0.01% |
41,494
+978
| +2% | +$12.6K |
|
2328
Vaalco Energy
EGY
$594M
| $398K | ﹤0.01% |
87,919
-9
| -0% | -$41 |
|
|
NXDR
2329
Nextdoor Holdings
NXDR
$986M
| $398K | ﹤0.01% |
184,987
+19,871
| +12% | +$42.4K |
|
|
NWLI
2330
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $397K | ﹤0.01% |
1,637
| – | – |
|
2331
SIGA Technologies
SIGA
$219M
| $395K | ﹤0.01% |
68,740
| – | – |
|
2332
Zymeworks
ZYME
$1.67B
| $392K | ﹤0.01% |
+43,400
| New | +$378K |
|
|
CTIC
2333
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $389K | ﹤0.01% |
92,700
+17,000
| +22% | +$88.2K |
|
2334
Montauk Renewables
MNTK
$255M
| $388K | ﹤0.01% |
49,269
+7,179
| +17% | +$72.8K |
|
2335
Procept Biorobotics
PRCT
$1.17B
| $386K | ﹤0.01% |
13,585
+1,257
| +10% | +$44.3K |
|
2336
i3 Verticals
IIIV
$342M
| $385K | ﹤0.01% |
15,712
| – | – |
|
2337
Sportsman's Warehouse
SPWH
$46M
| $385K | ﹤0.01% |
45,397
-4,467
| -9% | -$40.8K |
|
|
ME
2338
DELISTED
23andMe Holding Co
ME
| $383K | ﹤0.01% |
8,407
| – | – |
|
2339
Kimbell Royalty Partners
KRP
$1.48B
| $381K | ﹤0.01% |
25,020
| – | – |
|
2340
Vicor
VICR
$10.2B
| $378K | ﹤0.01% |
8,056
-8,992
| -53% | -$499K |
|
2341
LSB Industries
LXU
$693M
| $378K | ﹤0.01% |
36,600
+3,538
| +11% | +$43.1K |
|
2342
Haverty Furniture Companies
HVT
$454M
| $378K | ﹤0.01% |
11,837
-6,699
| -36% | -$227K |
|
|
GPMT
2343
Granite Point Mortgage Trust
GPMT
$61.2M
| $376K | ﹤0.01% |
75,803
+10,250
| +16% | +$59.6K |
|
2344
IonQ
IONQ
$16.6B
| $373K | ﹤0.01% |
60,581
-62,433
| -51% | -$292K |
|
|
LGTY
2345
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $372K | ﹤0.01% |
+29,464
| New | +$414K |
|
2346
G-III Apparel Group
GIII
$1.5B
| $371K | ﹤0.01% |
23,830
-14,129
| -37% | -$221K |
|
|
SOVO
2347
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $370K | ﹤0.01% |
22,169
-20,700
| -48% | -$291K |
|
2348
Kodiak Sciences
KOD
$2.84B
| $369K | ﹤0.01% |
59,558
-18,740
| -24% | -$131K |
|
2349
AnaptysBio
ANAB
$1.68B
| $368K | ﹤0.01% |
+16,921
| New | +$411K |
|
2350
Bank First Corp
BFC
$1.7B
| $366K | ﹤0.01% |
4,976
-3,500
| -41% | -$278K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.